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Phospholipases A2 (PLA2) represent a ubiquitous group of
enzymes serving a number of functions, from toxicity of several
venoms to phospholipid metabolism, digestion, cellular signaling, and
antimicrobial activity. These enzymes cleave the sn-2 acyl chain of
glycerophospholipids to yield lysophospholipids and free fatty acids
(FFA), and both their catalytic mechanism and structures are
conserved with a high degree of sequence homology between
different species, secretory PLA2 in particular [1,2].
The hallmark of lipolytic enzymes, including PLA2, is the so-called
interfacial activation: compared to the hydrolysis of monomeric
substrates their activity is dramatically enhanced when reacting
with phospholipid interfaces [3], such as those present in micelles,
monolayers, and bilayers. Three mechanistic models have been
proposed to explain this property. The enzyme model assumes that a
change in PLA2 conformation is induced by the interface [4], whereasthe substrate model assigns the activation to the physicochemical
properties of the interface [5]. Changes in PLA2 conformation upon
interfacial activation were recently demonstrated using Fourier
transform infrared spectroscopy, and it was suggested that enzyme
conformational alterations, in unison with the physical state of the
substrate, would cause the augmented catalytic activity [6,7]. Third
model, functional amyloid oligomer was recently forwarded by us [8].
De Haas and coworkers originally suggested ‘superactivation’ of PLA2
to be caused by the formation of PLA2 aggregates at interfaces [9], and
this was concluded also by Dennis and coworkers [10]. A critical
content of the hydrolytic products lysoPC and FFA, approx. X=0.08 is
required for the activation [11] and aggregation of PLA2 in the
presence of FFA and lysoPC has been demonstrated [12–14]. We
recently characterized this aggregation process in more detail and
observed the formation of amyloid-like ﬁbers stainingwith Congo Red
and thioﬂavin T in vitro upon the hydrolysis of DPPC by PLA2 [8]. These
ﬁbrils have been recently demonstrated also by atomic force and
ﬂuorescence microscopy of PLA2 acting on supported DPPC bilayers
[15,16], and more recently by using ﬂuorescence quenching [17].
Protein–peptide interaction, hetero-oligomerization, and ﬁbrillation
were observed to accompany also the activation of PLA2 by the
antimicrobial peptide temporin B [18]. Incubation of PLA2 with lysoPC
in vitro results in an inhibition of PLA2 [19] and the formation of ﬁbrils,
seen by electron microscopy [20], revealing a dual role of this lipid,
promoting both the initial activation and subsequent inhibition of PLA2,
resulting in a transient burst in activity.
In order to subject the aforementioned putative mechanism of PLA2
activity control to further testing, we used the molecular chaperone,
heat shock protein 70 (Hsp70),which has been demonstrated in several
Fig. 1. Hydrolysis as a function of time of 1.2 μM C28-O-PHPM by 2 nM phospholipase-
A2 with 2 μMATP-Mg2+ (Δ), or in the absence (○) and presence of 2 nMHsp70 as such
(□) and with 2 μMATP-Mg2+ (■) in 2.0 ml of 5 mMHEPES, 0.1 mM EDTA, 1 mM CaCl2,
pH 7.4 at 37 °C with stirring. Each point represents the average of three independent
experiments with the error bars giving the standard deviations. The symbols are not
individual data points but only one point out of 300, the continuous lines connecting
each data point.
Fig. 2. Hydrolytic activity as a function of time of 1.25 μM C28-O-PHPM by 2 nM PLA2
(○), by 2 nM PLA2 preincubatedwith 20 μM lysoPC prior to adding to the substrate (●),
or by 2 nM PLA2 preincubated with 20 μM lysoPC prior to adding the substrate to which
2 nM Hsp70 and 2 μM ATP-Mg2+ (■) were added. The reactions consist in 2.0 ml of
5 mM HEPES, 0.1 mM EDTA, 1 mM CaCl2, pH 7.4 at 37 °C with stirring, as described in
the legend for Fig. 1.
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such as α-synuclein and Aβ [21,22], these two proteins representing
paradigms for neurodegenerativediseases.More speciﬁcally, in the light
of the activity control mechanism deciphered in our previous studies,
Hsp70 should inﬂuence the oligomerization of PLA2, retaining the
enzyme longer as a catalytically active oligomer, sustaining activity by
attenuating the inactivation by conversion into amyloid. PLA2 catalyzed
phospholipid hydrolysis was measured using a pyrene labeled
phospholipid substrate, both with and without recombinant human
Hsp70.
2. Materials and methods
2.1. Materials
1-Octosanyl-2-(pyren-1-yl) hexanoyl-sn-glycero-3-phosphatidyl-
monomethyl ester (C28-O-PHPM) was from Invitrogen (Eugene, OR)
and lysoPC (1-hexadecanoly-2-lyso-sn-glycerol-3-phosphocholine)
from Avanti (Alabaster, AL). The purities of these lipids were checked
by thin layer chromatography on silicic acid coated plates (Merck,
Darmstadt, Germany) developed with a chloroform/methanol/water
mixture (65:25:4, v/v/v). Examination of the plates after iodine
staining revealed no impurities. Bee venom PLA2 was from Sigma and
its purity was veriﬁed by polyacrylamide gel electrophoresis in the
presence of SDS. Hsp70 was expressed and puriﬁed as described
previously [23]. All other chemicals were of analytical grade and from
standard sources. The concentration of the pyrene labeled lipids was
determined from absorbance at 342 nm using 42,000 cm−1 as the
molar extinction coefﬁcient for the pyrene labeled lipid in ethanol.
Concentrations of other lipid stock solutions in chloroform were
determined gravimetrically with a high-precision electrobalance
(Cahn, Cerritos, CA), as described [24]. Freshly deionized ﬁltered
water (Milli RO/Milli Q, Millipore Inc., Jeffrey, NH) was used in all
experiments. CaCl2 solution was prepared and ﬁltered through a
0.2 μmﬁlter (Schleicher & ShuellMicroscience, Dassel, Germany) prior
to use.
2.2. Assay for PLA2
PLA2 activity was determined by the kinetic assay described
previously [25–28]. Appropriate amounts of the stock solution of the
pyrene-labeled PLA2 substrate C28-O-PHPM were dried under a
stream of nitrogen followed by high vacuum for a minimum of 2 h.
The lipid residues were subsequently dissolved in ethanol to yield a
lipid concentration of 50 μM, and aliquots of this ethanolic lipid
solution were rapidly injected into the buffer in ﬁve 10 μl aliquots
with a Hamilton micropipette to obtain a ﬁnal concentration of
1.25 μM C28-O-PHPM in a total volume of 2 ml. Fluorescence
intensities were measured with a Varian Carey spectroﬂuorometer
with an excitation wavelength of 344 nm, and emission at 400 and
480 nm, with both emission and excitation bandpasses set at 5 nm,
using magnetically stirred four window quartz cuvettes (with 10 mm
path length) at 37 °C. After 5 min of equilibration the reactions were
initiated by adding 4 pmoles of bee venom PLA2. The progress of
phospholipid hydrolysis was followed by measuring the pyrene
monomer intensity at 400 nm as a function of time. The assay was
calibrated by adding known picomolar aliquots of (pyren-1-yl)
hexanoate into the reaction mixture in the absence of enzyme while
recording pyrene monomer emission intensity. The activity of the
enzyme was calculated from the initial velocity of the reaction kinetic
curves and converted to pmoles FFA min−1 ml−1.
When indicated 2 nM of Hsp70 was added to the cuvette
containing 1.25 μM C28-O-PHPM 5 min prior to the addition of
PLA2. In some experiments (PLA2 ﬁnal concentration 2 nM) was
preincubated for 5 min at 37 °C with 0 or 20 μM lysoPC prior to the
addition into the ﬂuorescent substrate with or without Hsp70, asindicated. All reactions were repeated 3–4 times and standard
deviations for data points were obtained for the curves using Origin.3. Results and discussion
PLA2s constitute a large family of structurally related enzymes [2].
Bee venom PLA2 belongs to group III enzymes and has been
thoroughly studied. The ﬂuorescent lipid C28-O-PHPM analog is
avidly hydrolyzed by the bee venom enzyme, causing an increase in
pyrene monomer ﬂuorescence (Im) and a concomitant decrease in
pyrene excimer ﬂuorescence. These changes in ﬂuorescence provide
an easy method to monitor the rate and extent of phospholipid
hydrolysis [25–27,29]. With the negatively charged phospholipid
C28-O-PHPM the hydrolysis starts immediately with no measurable
preceding lag (44). This could be due to the negative lipid headgroup
chargewhich has been shown to generically promote the formation of
Fig. 3. A schematic model for the activation of PLA2 by Hsp70 in presence of ATP-Mg2+ by the attenuation of the conversion of the catalytically active protoﬁbrils into inactive
amyloid ﬁbers.
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Aβ [31] and prion protein [32,33].
The following mechanistic sequence was forwarded by us to
explain the lag-burst behavior upon hydrolysis of a phospholipid such
as DPPC, the interfacial activation of PLA2 and subsequent inhibition
of PLA2. More speciﬁcally i) the soluble enzyme ﬁrst rapidly binds to
the substrate, ii) where after there is slow accumulation of the
reaction products [18,34,35]. iii) In the presence of the latter toward
the end of the latency period there is a loosening of the PLA2 tertiary
structure, caused by the locally enriched products lysoPC and FFA [14],
resulting in a transition into a molten globule state [8]. This is
accompanied by a fast change in PLA2 conformation, signaled by an
increment in the emission from ﬂuorophore labeled PLA2 or from the
intrinsic ﬂuorophore Trp [8]. iv) After the latency period a burst in
the activity of PLA2 takes place. We have suggested this to result from
the formation of low molecular weight oligomers, leading to the
nucleation of formation of oligomers (amyloid type ‘protoﬁbrils’),
evident as a pronounced increase in anisotropy [8]. The highly active
oligomers produce enhanced ﬂuorescence upon ThT staining and are
thus likely to represent amyloid protoﬁbrils. With time the latter
develop into vi) catalytically inactive amyloid ﬁbers exhibiting the
characteristic blue-green ﬂuorescence upon Congo red staining [8],
accommodating into a minimum in the folding/aggregation free
energy landscape, this process acting as a thermodynamic on-off
switch controlling enzyme activity (8).3.1. Hsp70 sustains PLA2 activity
Hsp70 functions as a chaperonebyprotecting cells against stress that
causes protein denaturation, and also serves a house-keeping role,
including dissolution of insoluble protein complexes, folding and
refolding of proteins and control of regulatory proteins [36]. Hsp70
requires ATP and Mg+2 for activity [36–38] and consists of two major
functional domains, the N-terminal ATPase domainwhich also provides
a phospholipid binding site [39,40], and the C-terminal peptide binding
domain [41,42]. Hsp70 can prevent amyloid aggregation of proteins by
accommodating these in its protein binding site [38], and has been
shown to inhibit the assembly ofα-synuclein ﬁbrils through a transient
interactionmechanismwhich does not require ATP-mediated refolding
[22,43], with the Hsp70 substrate binding domain interacting with
partially unfolded α-synuclein intermediates.
In this study we subjected the aforementionedmechanism of PLA2
activity control to further testing using Hsp70. More speciﬁcally in the
light of the aforementioned Hsp70 can be expected to attenuate the
oligomerization of PLA2 and its transformation into amyloid ﬁbers as
previously observed with other amyloid forming proteins [44].
Accordingly, we investigated if Hsp70 could sustain the expression
of the PLA2 activity. A small increase in the extent of hydrolysis was
observed in the presence of Hsp70 without ATP when compared with
the reaction of PLA2 alone (Fig. 1), thus suggesting direct interaction
between Hsp70 and PLA2 in a manner slightly assisting the hydrolytic
action of the latter enzyme. However, when PLA2 was added to the
substrate with Hsp70 in the presence of ATP and Mg+2 the overall
amount of products formed was increased by 30% (Fig. 1). This resultcomplies with the hypothesis that Hsp70 attenuates, in a manner
requiring ATP the conversion of PLA2 into inactive amyloid ﬁbers.
In the second series of experiments we studied if Hsp70 could
rescue the activity of PLA2 under conditions where amyloid formation
is enhanced by lysoPC induced inhibition of PLA2 [20]. Accordingly,
we accelerated amyloid oligomerization of PLA2 by preincubation
with lysoPC [20] (Fig. 2). As expected [20] this preincubation of PLA2
with lysoPC reduces the extent of hydrolysis (Fig. 2). However, when
Hsp70 is present together with ATP andMg+2 the amount of products
is signiﬁcantly increased compared to the assay of PLA2 alone as well
as for PLA2 preincubated with lysoPC (Fig. 2).
The foregoing experiments demonstrate that Hsp70 can rescue the
activity of PLA2 in an ATP dependent manner, most likely attenuating
the conversion of active protoﬁbrils into inactive amyloid ﬁbers
(Fig. 3), resulting in more extensive hydrolysis. Along these lines,
Hsp70 may increase the activity of other lipid-activated enzymes by
mechanisms similar to that proposed by us for PLA2 [8]. Literature
survey suggested one such enzyme to be protein kinase C (PKC) [8].
While for this enzyme the involvement of phosphorylation makes the
actual mechanism more complicated than for PLA2, it is of interest
that the activation of PKC has been reported to be accompanied by
aggregation [45], and another study demonstrated that Hsp70 serves
as a stabilizing factor for PKC, prolonging the lifetime of the active
state of PKC, sustaining the expression of its catalytic activity [46].
Accordingly, the more general nature of functional amyloid oligomer
formation in the control of membrane associated enzymes appears to
be feasible and warrants further studies.
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